Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of IBI-10090 in Cataract Surgery
NCT01048593Phase 2Terminated
- Sponsor
- Icon Bioscience, Inc.
- Start
- Jan 2010
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in ocular inflammation, sponsored by Icon Bioscience, Inc.. Started Jan 2010; status: terminated.
02
Drugs
dexamethasone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01048593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048593.